PC-SPES: Hope or Hype?
- 15 September 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (18) , 3657-3659
- https://doi.org/10.1200/jco.2004.06.920
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Oxaliplatin (L-OHP) in combination with 5-fluorouracil (5-FU)/l-leucovorin (l-LV) on modified Roswell Park regimen as first-line treatment of advanced colorectal cancer (ACRC): A phase I/II studyJournal of Clinical Oncology, 2004
- Herbal Composition PC-SPES for Management of Prostate Cancer: Identification of Active PrinciplesJNCI Journal of the National Cancer Institute, 2002
- Effects of St. John's Wort on Irinotecan MetabolismJNCI Journal of the National Cancer Institute, 2002
- Acquired Bleeding Diathesis in a Patient Taking PC-SPESNew England Journal of Medicine, 2001
- Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancerUrology, 2001
- Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate CancerJournal of Clinical Oncology, 2000
- HERBAL THERAPY PC-SPES: IN VITRO EFFECTS AND EVALUATION OF ITS EFFICACY IN 69 PATIENTS WITH PROSTATE CANCERJournal of Urology, 2000
- PC‐SPES, a dietary supplement for the treatment of hormone‐refractory prostate cancerBJU International, 2000
- Trends in Alternative Medicine Use in the United States, 1990-1997JAMA, 1998
- Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate CancerNew England Journal of Medicine, 1998